Volume 14, Issue 5, Pages (November 2011)

Slides:



Advertisements
Similar presentations
Volume 5, Issue 10, Pages (October 2016)
Advertisements

Volume 21, Issue 2, Pages (October 2017)
Volume 14, Issue 6, Pages (December 2011)
Volume 9, Issue 3, Pages (March 2009)
Volume 20, Issue 3, Pages (July 2017)
Volume 15, Issue 1, Pages (January 2012)
Volume 22, Issue 8, Pages (February 2018)
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
Volume 16, Issue 10, Pages (September 2016)
Volume 11, Issue 3, Pages (March 2010)
Volume 21, Issue 2, Pages (October 2017)
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
Volume 6, Issue 3, Pages (September 2007)
Volume 17, Issue 4, Pages (April 2013)
Volume 6, Issue 3, Pages (September 2007)
Volume 22, Issue 3, Pages (March 2015)
Volume 21, Issue 11, Pages (December 2017)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Endocrine Regulation of Energy Metabolism by the Skeleton
Volume 5, Issue 2, Pages (February 2007)
Volume 15, Issue 5, Pages (May 2012)
Volume 25, Issue 2, Pages (February 2017)
Insulin Signaling in α Cells Modulates Glucagon Secretion In Vivo
Volume 18, Issue 5, Pages (November 2013)
Volume 20, Issue 1, Pages (July 2014)
Protection against High-Fat-Diet-Induced Obesity in MDM2C305F Mice Due to Reduced p53 Activity and Enhanced Energy Expenditure  Shijie Liu, Tae-Hyung.
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Regulation of Hepatic Energy Metabolism and Gluconeogenesis by BAD
Circadian Disruption Leads to Insulin Resistance and Obesity
Critical Role for Hypothalamic mTOR Activity in Energy Balance
Volume 23, Issue 6, Pages (June 2016)
Volume 16, Issue 4, Pages (October 2012)
Volume 13, Issue 2, Pages (February 2011)
Volume 21, Issue 5, Pages (May 2015)
Volume 17, Issue 8, Pages (November 2016)
Volume 17, Issue 4, Pages (April 2013)
Volume 6, Issue 4, Pages (October 2007)
Volume 10, Issue 5, Pages (November 2009)
Volume 8, Issue 2, Pages (August 2008)
Volume 8, Issue 4, Pages (October 2008)
Volume 9, Issue 1, Pages (January 2009)
Volume 5, Issue 5, Pages (May 2007)
Volume 1, Issue 4, Pages (April 2005)
Volume 24, Issue 8, Pages e7 (August 2018)
Volume 15, Issue 5, Pages (May 2012)
Volume 6, Issue 1, Pages (July 2007)
Volume 6, Issue 3, Pages (September 2007)
Volume 14, Issue 4, Pages (October 2011)
Volume 14, Issue 5, Pages (November 2011)
Roles for leptin receptor/STAT3-dependent and -independent signals in the regulation of glucose homeostasis  Sarah H. Bates, Rohit N. Kulkarni, Matthew.
Volume 9, Issue 6, Pages (June 2009)
Volume 15, Issue 6, Pages (June 2012)
Volume 134, Issue 6, Pages (September 2008)
Volume 8, Issue 5, Pages (November 2008)
Volume 12, Issue 6, Pages (December 2010)
A Non-invasive Method to Assess Hepatic Acetyl-CoA In Vivo
Volume 14, Issue 5, Pages (November 2011)
Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice  Decheng Ren, Minghua Li, Chaojun Duan, Liangyou.
Volume 7, Issue 6, Pages (June 2008)
Mice with AS160/TBC1D4-Thr649Ala Knockin Mutation Are Glucose Intolerant with Reduced Insulin Sensitivity and Altered GLUT4 Trafficking  Shuai Chen, David.
Lipin, a lipodystrophy and obesity gene
Volume 4, Issue 5, Pages (November 2006)
Volume 18, Issue 1, Pages (July 2013)
Volume 132, Issue 3, Pages (February 2008)
Volume 5, Issue 6, Pages (June 2007)
Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice  Jun Yoshino, Kathryn F. Mills,
Volume 26, Issue 1, Pages 1-10.e7 (January 2019)
Volume 6, Issue 6, Pages (December 2007)
Volume 4, Issue 4, Pages (October 2006)
Presentation transcript:

Volume 14, Issue 5, Pages 587-597 (November 2011) Dissociation of the Glucose and Lipid Regulatory Functions of FoxO1 by Targeted Knockin of Acetylation-Defective Alleles in Mice  Alexander S. Banks, Ja Young Kim-Muller, Teresa L. Mastracci, Natalie M. Kofler, Li Qiang, Rebecca A. Haeusler, Michael J. Jurczak, Dina Laznik, Garrett Heinrich, Varman T. Samuel, Gerald I. Shulman, Virginia E. Papaioannou, Domenico Accili  Cell Metabolism  Volume 14, Issue 5, Pages 587-597 (November 2011) DOI: 10.1016/j.cmet.2011.09.012 Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 1 FoxO1 Acetylation and Localization (A) Immunoblot analysis of FoxO1 acetyllysine content in epididymal adipose tissue extracts from mice subjected to fasting and re-refeeding. (B) Fluorescence microscopy of primary mouse hepatocytes transduced with FoxO1-GFP-WT, -KR, or -KQ adenoviruses and maintained in serum-free medium (upper panel) or incubated with insulin (lower panel). We show representative images. (C and D) Immunoblotting analysis of FoxO1 content in nuclear and cytosolic fractions isolated from epididymal adipose tissue extracts of fasted (C) or refed (D) wild-type (WT) or Foxo1KR/KR (KR) animals. We used nucleophosmin (NPM) or tubulin as markers of cellular fractions in (C) and Hdac1 or β-actin in (D). Cell Metabolism 2011 14, 587-597DOI: (10.1016/j.cmet.2011.09.012) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 2 Embryonic Lethality in Mice Homozygous for the Foxo1KQ/KQ Mutation (A and B) Microphotographs of Foxo1+/+ and Foxo1KQ/KQ embryos at E10.5 and E11.5. (C and D) Microphotographs of E9.5 embryos showing first (I) and second branchial arch (II), as well as atrioventricular canal (AVC) and ventricle (V). Arrow in D indicates the distended AVC in the mutant. (E and F) Histological sections of E9.5 embryos across the AVC (arrows) and ventricle. (G–L) Whole-mount PECAM-1 immunostaining with details of the aortic arch arteries in the head (arrowheads in (I), missing in (J) and the dorsal aorta (arrows) in the tail region (K and L) of a Foxo1+/+ (G, I, and K) and Foxo1KQ/KQ embryo (H, J, and L). Asterisks in K and L mark somites, which are smaller in the mutant. (M and N) Histological sections through the first branchial arch showing dorsal aortae (arrows in M) and the first branchial arch artery (arrowheads in M). (M' and N') Sections through more posterior regions showing paired dorsal aortae (arrows that are distended in the mutant (N') compared with wild-type (M'). (O and P) Vascular plexus in the yolk sac in Foxo1KQ/KQ and wild-type embryos shown by immunostaining for PECAM. Cell Metabolism 2011 14, 587-597DOI: (10.1016/j.cmet.2011.09.012) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 3 Metabolic Data in Foxo1KR/KR Mice (A) HOMA-IR values calculated from the data in Table S2. (B) Pyruvate tolerance tests in WT and Foxo1KR/KR mice. (C–E) Glucose infusion rates (C), endogenous glucose production under hyperinsulinemic conditions (D), and glycolysis during euglycemic hyperinsulinemic clamps (E). (F) Determination of TG content in lipoprotein fractions isolated by FPLC analysis. (G) Basal and isoproterenol-stimulated glycerol release from primary cultures of epididymal fat pads. n = ≥ 6 mice per group and each experiment. ∗p < 0.05; ∗∗p < 0.01 by 2-way ANOVA. Data are presented as means ± SEM. Cell Metabolism 2011 14, 587-597DOI: (10.1016/j.cmet.2011.09.012) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 4 Gene Expression Analysis (A–C) Hepatic expression of genes involved in glucose (A) and lipid metabolism (B and C) in 2-month-old male mice. (D) Adipose expression of fatty acid and TG synthetic genes in the same cohort. n = ≥ 6 for each genotype. ∗ = p < 0.05, ∗∗ = p < 0.01 by Student's t test. Data are presented as means ± SEM. Cell Metabolism 2011 14, 587-597DOI: (10.1016/j.cmet.2011.09.012) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 5 Characterization of Foxo1KR/KR Mice in Dietary and Genetic Models of Insulin Resistance (A–C) Body weight curves (A), body composition (B), and intraperitoneal glucose tolerance tests (C) in WT and Foxo1KR/KR mice during high-fat feeding. (D–H) Body weight (D); 16 h fasting glucose levels (E); insulin levels in random fed, 16 h fasted, and 4 h refed mice (F); and glucose tolerance tests in male (G) and (H) female db/db and Foxo1KR/KR;db/db mice. (I–K) Fasting glucose levels (I); fed, fasted, and refed insulin levels (J); and glucose tolerance tests (K) in male InsR+/− and Foxo1KR/KR;InsR+/− (KR-InsR+/−) mice. n = 6-12 for each genotype and each experiment. ∗ = p < 0.05, ∗∗ = p < 0.01 by 2-way ANOVA. Data are presented as means ± SEM. Cell Metabolism 2011 14, 587-597DOI: (10.1016/j.cmet.2011.09.012) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 6 Energy Homeostasis Studies (A–F) Food intake (A), body weight (B), energy expenditure as measured by CO2-produced (VCO2) (C), respiratory exchange ratio (CO2-produced/O2 consumed) (RER) (D), locomotor activity (E), and metabolic efficiency plots (F) in 2-month-old WT and Foxo1KR/KR mice maintained on standard chow diet. n = 8 for each genotype and each experiment. ∗ = p < 0.05 by 2-way ANOVA. Data are presented as means ± SEM. Cell Metabolism 2011 14, 587-597DOI: (10.1016/j.cmet.2011.09.012) Copyright © 2011 Elsevier Inc. Terms and Conditions